Evidence map›Paper›PMID 37219707›Full record

ArticleGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2023

The methylation level of a single cancer risk marker gene reflects methylation burden in gastric mucosa.

Takahiro Irie, Harumi Yamada, Chihiro Takeuchi, Yu-Yu Liu, Hadrien Charvat, Taichi Shimazu, Takayuki Ando, Takao Maekita, Seiichiro Abe, Hiroyuki Takamaru and 5 more

Open access · bronzeAbstract read
PubMed Publisher
In one paragraph

Article in Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Concurrent hypermethylation of CpG islands and hypomethylation of CpG-poor regions are associated with gastric cancer risk after Helicobacter pylori eradication.Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association · 2025
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 7 institutions in 1 country.

Takahiro IrieDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.
Harumi YamadaDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.
Chihiro TakeuchiDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.
Yu-Yu LiuDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan.
Hadrien CharvatFaculty of International Liberal Arts, Juntendo University, Tokyo, Japan.
Taichi ShimazuDivision of Behavioral Sciences, National Cancer Center Institute for Cancer Control, National Cancer Center, Tokyo, Japan.
Takayuki AndoThird Department of Internal Medicine, University of Toyama, Toyama, Japan.
Takao MaekitaSecond Department of Internal Medicine, Wakayama Medical University, Wakayama, Japan.
Seiichiro AbeEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Hiroyuki TakamaruEndoscopy Division, National Cancer Center Hospital, Tokyo, Japan.
Masaaki KodamaDepartment of Gastroenterology Faculty of Medicine, Oita University, Oita, Japan.
Kazunari MurakamiDepartment of Gastroenterology Faculty of Medicine, Oita University, Oita, Japan.
Kiichi SugimotoDepartment of Coloproctological Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Kazuhiro SakamotoDepartment of Coloproctological Surgery, Juntendo University Graduate School of Medicine, Tokyo, Japan.
Toshikazu UshijimaDepartment of Epigenomics, Institute for Advanced Life Sciences, Hoshi University, Tokyo, Japan. tushijima142@hoshi.ac.jp.ORCID 0000-0003-3405-7817
Juntendo University · JPHoshi University · JPNational Cancer Center Hospital East · JPOita University · JPKyoto University · JPUniversity of Toyama · JPWakayama Medical University · JP

Funding

AMED 22ck0106552h9903
6 · The paper itself

Abstract

backgroundGastric cancer risk can be accurately predicted by measuring the methylation level of a single marker gene in gastric mucosa. However, the mechanism is still uncertain. We hypothesized that the methylation level measured reflects methylation alterations in the entire genome (methylation burden), induced by Helicobacter pylori (H. pylori) infection, and thus cancer risk.

methodsGastric mucosa of 15 healthy volunteers without H. pylori infection (G1), 98 people with atrophic gastritis (G2), and 133 patients with gastric cancer (G3) after H. pylori eradication were collected. Methylation burden of an individual was obtained by microarray analysis as an inverse of the correlation coefficient between the methylation levels of 265,552 genomic regions in the person's gastric mucosa and those in an entirely healthy mucosa.

resultsThe methylation burden significantly increased in the order of G1 (n = 4), G2 (n = 18), and G3 (n = 19) and was well correlated with the methylation level of a single marker gene (r = 0.91 for miR124a-3). The average methylation levels of nine driver genes tended to increase according to the risk levels (P = 0.08 between G2 vs G3) and was also correlated with the methylation level of a single marker gene (r = 0.94). Analysis of more samples (14 G1, 97 G2, and 131 G3 samples) yielded significant increases of the average methylation levels between risk groups.

conclusionsThe methylation level of a single marker gene reflects the methylation burden, which includes driver gene methylation, and thus accurately predicts cancer risk.

Indexed as

Gastritis, AtrophicHelicobacter InfectionsHelicobacter pyloriStomach NeoplasmsDNA MethylationGastric MucosaHumansRisk FactorsDriver gene methylationGastric cancerMethylation burdenRisk prediction

Identifiers

PMID37219707
OpenAlexW4377564413

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.